Welcome to our dedicated page for Marpai news (Ticker: MRAI), a resource for investors and traders seeking the latest updates and insights on Marpai stock.
Marpai, Inc. (MRAI) is a technology platform company whose subsidiaries provide Third-Party Administration (TPA), Pharmacy Benefit Management (PBM) and value-oriented health plan services to employers that directly pay for employee health benefits. This news page aggregates company-issued updates and related coverage so readers can follow how Marpai describes its progress in the self-funded employer health plan market.
Recent Marpai news has focused on its turnaround strategy, cost discipline and operational efficiency, as well as developments in its TPA and PBM offerings. The company has reported reductions in operating expenses and changes in operating loss and net loss over multiple quarters, and it links these trends to efforts to streamline operations and adjust its business model. News releases also highlight private placements and other capital transactions disclosed in Form 8-K filings, which Marpai states are intended to support working capital and general corporate purposes.
Marpai’s updates describe initiatives such as the Marpai Saves program and the relaunch of MarpaiRx, its PBM solution, which the company positions as part of its approach to serving self-funded employer health plans. Other announcements discuss network access agreements, including access to the Aetna Signature Administrator PPO network, and the addition of tools like the Aetna Faircost Optimizer for managing out-of-network claims costs.
Investors and observers can use this news feed to review Marpai’s own descriptions of its financial results, strategic initiatives, technology platform developments and capital raising activities. For a fuller picture, readers may compare these news items with the company’s SEC filings and other official disclosures.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Marpai, Inc. (Nasdaq: MRAI) has successfully closed a public offering of 7,400,000 shares at a price of
Marpai, Inc. (Nasdaq: MRAI) has announced an underwritten public offering of 7,400,000 shares of its common stock priced at
The proceeds will be used primarily for debt repayment related to the acquisition of Maestro Health (at least 35% of the funds) and the remainder for general corporate purposes. The offering is filed under a shelf registration statement with the SEC. ThinkEquity is the sole book-running manager for the offering.
Marpai, Inc. (Nasdaq: MRAI) announced its intention to conduct an underwritten public offering of its common stock, with all shares being sold by the Company. ThinkEquity is acting as the sole book-running manager for this offering. The exact size and terms remain uncertain as the offering is contingent upon market conditions.
The net proceeds from the offering will be used primarily for repaying debt incurred from the acquisition of Maestro Health, with at least 35% allocated for this purpose, while the remainder will cover general corporate uses.
The offering will be registered under an existing SEC Form S-3 shelf registration statement. No sales will occur in jurisdictions where the offering would be unlawful without proper registration or qualification.
Marpai, Inc. (Nasdaq: MRAI) reported a significant 54% increase in revenue for the fourth quarter of 2022, totaling approximately $7.6 million compared to $4.9 million in Q3 2022. This growth is primarily attributed to the acquisition of Maestro Health. For the full year 2022, net revenues reached $24.3 million, up 71% from 2021. However, the company also faced increased operating losses of approximately $8.9 million in Q4 2022 and a full-year net loss of $26.5 million. Financial guidance for 2023 anticipates revenues between $34 million and $35 million.
Marpai, Inc. (Nasdaq: MRAI) is set to host a conference call on March 30, 2023, at 8:30 a.m. ET to discuss its operational and financial highlights for the fourth quarter and full year of 2022. The results will be released after trading on March 29, 2023. The company specializes in AI-powered health plan services aimed at self-funded employer health plans, competing in a $22 billion Third Party Administrator sector. Investors can join via phone or through a webcast available on their official site.